Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody Treatment

NEXT STORY
Novan Initiates B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
PREV STORY
CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Honolulu Ophthalmologist Implants First Visian® Toric ICL in Hawaii

Dr. Alan Faulkner of Aloha Laser Vision uses the FDA-approved Visian Toric ICL (TICL) ...

author_avatar
NASDAQ Market News

Humanigen Appoints Robert Savage to Board of Directors

BRISBANE, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Life Foundation Offers 2016 Life Grants to Assist Those with Infertility

CHICAGO, April 12, 2016 (GLOBE NEWSWIRE) -- The Kevin J. Lederer Life Foundation, a ...

author_avatar
NASDAQ Market News